Literature DB >> 10457225

Normal human immunoglobulin G4 is bispecific: it has two different antigen-combining sites.

J Schuurman1, R Van Ree, G J Perdok, H R Van Doorn, K Y Tan, R C Aalberse.   

Abstract

Unlike other immunoglobulin G (IgG) subclasses, IgG4 antibodies in plasma have been reported to be functionally monovalent. In this paper we show that the apparent monovalency of circulating IgG4 is caused by asymmetry of plasma IgG4. A large fraction of plasma IgG4 molecules have two different antigen-binding sites, resulting in bispecificity. Sera from patients with IgG4 antibodies to both house dust mite and grass pollen induced cross-linking of Sepharose-bound grass pollen antigen to radiolabelled house dust mite allergen Der p I. This bispecific binding activity was not observed in sera with IgG4 antibodies to either grass pollen or house dust mite exclusively. Depletion of IgG4 antibodies resulted in disappearance of the bispecific activity. By size exclusion chromatography we excluded the possibility that bispecific activity was caused by aggregation of IgG4 antibodies. These results indicate that circulating (polyclonal) IgG4 antibodies have two different antigen-binding sites and therefore are functionally monovalent antibodies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10457225      PMCID: PMC2326875          DOI: 10.1046/j.1365-2567.1999.00845.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Characterization with monoclonal and polyclonal antibodies of a new major allergen from grass pollen in the group I molecular weight range.

Authors:  R van Ree; J G Clemens; M Aalbers; S O Stapel; R C Aalberse
Journal:  J Allergy Clin Immunol       Date:  1989-01       Impact factor: 10.793

2.  Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency.

Authors:  J S van der Zee; P van Swieten; R C Aalberse
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

3.  IgG4 as a blocking antibody.

Authors:  R C Aalberse; P H Dieges; V Knul-Bretlova; P Vooren; M Aalbers; J van Leeuwen
Journal:  Clin Rev Allergy       Date:  1983-06

4.  Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response.

Authors:  R C Aalberse; R van der Gaag; J van Leeuwen
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

5.  An in vitro system for studying the kinetics of interchain disulfide bond formation in immunoglobulin G.

Authors:  J G Petersen; K J Dorrington
Journal:  J Biol Chem       Date:  1974-09-10       Impact factor: 5.157

6.  Structural motifs involved in human IgG antibody effector functions.

Authors:  J Greenwood; M Clark; H Waldmann
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

7.  Inhibition of complement activation by IgG4 antibodies.

Authors:  J S van der Zee; P van Swieten; R C Aalberse
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

8.  Skin tests and histamine release with P1-depleted Dermatophagoides pteronyssinus body extracts and purified P1.

Authors:  J S van der Zee; P van Swieten; H M Jansen; R C Aalberse
Journal:  J Allergy Clin Immunol       Date:  1988-05       Impact factor: 10.793

9.  FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting.

Authors:  C A Fulcher; S de Graaf Mahoney; T S Zimmerman
Journal:  Blood       Date:  1987-05       Impact factor: 22.113

10.  Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

Authors:  M Brüggemann; G T Williams; C I Bindon; M R Clark; M R Walker; R Jefferis; H Waldmann; M S Neuberger
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  39 in total

Review 1.  Stability of IgG isotypes in serum.

Authors:  Ivan R Correia
Journal:  MAbs       Date:  2010-05-16       Impact factor: 5.857

2.  Engineering an improved IgG4 molecule with reduced disulfide bond heterogeneity and increased Fab domain thermal stability.

Authors:  Shirley J Peters; C Mark Smales; Alistair J Henry; Paul E Stephens; Shauna West; David P Humphreys
Journal:  J Biol Chem       Date:  2012-05-18       Impact factor: 5.157

3.  Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress.

Authors:  Takahiko Ito; Kouhei Tsumoto
Journal:  Protein Sci       Date:  2013-09-30       Impact factor: 6.725

4.  Fab-arm exchange.

Authors:  Ellen Broug; Philip A Bland-Ward; John Powell; Kevin S Johnson
Journal:  Nat Biotechnol       Date:  2010-02       Impact factor: 54.908

5.  The S228P mutation prevents in vivo and in vitro IgG4 Fab-arm exchange as demonstrated using a combination of novel quantitative immunoassays and physiological matrix preparation.

Authors:  John-Paul Silva; Olivia Vetterlein; Joby Jose; Shirley Peters; Hishani Kirby
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

6.  Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange.

Authors:  Aran F Labrijn; Joyce I Meesters; Bart E C G de Goeij; Ewald T J van den Bremer; Joost Neijssen; Muriel D van Kampen; Kristin Strumane; Sandra Verploegen; Amitava Kundu; Michael J Gramer; Patrick H C van Berkel; Jan G J van de Winkel; Janine Schuurman; Paul W H I Parren
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

Review 7.  IgG4 breaking the rules.

Authors:  Rob C Aalberse; Janine Schuurman
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

8.  Controlled Fab-arm exchange for the generation of stable bispecific IgG1.

Authors:  Aran F Labrijn; Joyce I Meesters; Patrick Priem; Rob N de Jong; Ewald T J van den Bremer; Muriel D van Kampen; Arnout F Gerritsen; Janine Schuurman; Paul W H I Parren
Journal:  Nat Protoc       Date:  2014-09-25       Impact factor: 13.491

9.  Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.

Authors:  Robert W Maitta; Kausik Datta; Andrew Lees; Shelley Sims Belouski; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Production of native bispecific antibodies in rabbits.

Authors:  Wei Wang; Ruihuan Xu; Jinming Li
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.